Characteristics of the main groups of human host-defensive peptides;Egyes humán gazdavédo peptidek jellegzetességei

Orvosi Hetilap

Volumn 150, Issue 3, 2009, Pages 109-119

  Lapis, Károly ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NONE   (Hungary)

Author keywords

Antimicrobial peptides; Cathelicidins; Defensins; Granulysins; Histatins; Host defensive peptides

Indexed keywords

ALPHA DEFENSIN; ANTIINFECTIVE AGENT; BETA DEFENSIN; CATHELICIDIN; DEFENSIN; GNLY PROTEIN, HUMAN; HISTATIN; T LYMPHOCYTE ANTIGEN;

ADAPTIVE IMMUNITY; ARTICLE; DENDRITIC CELL; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; LYMPHOCYTE; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; REVIEW;

ALPHA-DEFENSINS; ANTI-INFECTIVE AGENTS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BETA-DEFENSINS; CATHELICIDINS; DEFENSINS; DENDRITIC CELLS; HISTATINS; HUMANS; IMMUNITY, INNATE; LYMPHOCYTE ACTIVATION; LYMPHOCYTES;

EID: 62249106715     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2009.28512     Document Type: Article

References (47)

1. De Smet, K., Contreras, R.: Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol. Lett., 2005, 27, 1337-1347.
2. Oppenheim, J. J., Biragyn, A., Kwak, L. W. és mtsa: Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann. Rheum. Dis., 2003, 62 (Suppl) IIii17-ii21.
3. Krensky, A. M.: Granulysin: a novel antimicrobial peptide of cytolytic T limphocytes and natural killer cells. Biochem. Pharmacol., 2000, 59, 317-320.
4. Xiao, J., Hughes, A., L., Ando, J. és mtsai: A genome wide screens identifi es a single β-defensin gene cluster on the chicken: implication for the origin and evolution of mammalian defensins. BMC Genomics, 2004, 5, 56. Doi: 10.1186/1471-2164-5-56; http//www.biomedcentral.com/1471-2164/ 5//56
5. Wang, G., Stange, E. F., Wehkamp, J.: Host-microbe interaction: mechanisms of defensin defi ciency in Crohn's disease. Expert Rev. Anti. Infect. Ther., 2007, 5/6, 1049-1057.
6. Lehrer, R. I.: Multispecific myeloid defensins. Curr. Opin. Hematol., 2007, 14, 16-21.
7. Chen, H., Xu, Z., Peng, L. A. és mtsai: Recent advances in the research and development of human defensins. Peptides, 2006, 27, 931-940.
8. Schneider, J. J., Unholzer, A., Schaller, M. és mtsai: Human defensins. J. Mol. Med., 2005, 83, 587-595.
9. Lehrer, R. I.: Primate defensins. Nat. Rev. Microbiol., 2004, 2, 727-738.
10. Shures, A., Verma, C. H.: Modelling study of dimerization in mammalian defensins. BMC Bioinformatics, 2006, 7 (Suppl. 5) 517. Doi: 10,1186/1471.2105-7-55-517.
11. Roitt, I., Brostoff, J., Male, D.: Immunology (6th edition). Mosby, Edinburgh, London, New York, 2001.
12. Gallo, R. L., Murakami, M., Ohtake, T. és mtsa: Biology and clinical relevance of naturally occurring antimicrobial peptides. J. Allergy Clin. Immunology, 2002, 110, 823-831.
13. Kim, Ch., Kaufmann, St., H. E.: Defensin: a multifunctional molecule lives up to its versatile name. Trend Microbiol., 2006, 14, 428-431.
14. Huttner, K. M., Bewins, Cl.: Antimicrobial peptides as mediators of epthelial host defence. Pediatr. Res., 1999, 45, 785-794
15. Bewins, Ch. L.: Events at the Host-Microbial Interface of the Gastrointestinal Tract V. Paneth cell α-defensins in intestinal host defense: Am. J. Physiol. Gastrointest. Liver Phys., 2005, 289, G173-G176.
16. Meyer-Hoffert, U., Hornef, M. W., Henriques-Normark, B. és mtsai: Secreted enteric antimicrobial activity localises to mucus surface layer. Gut, 2008, 57, 764-771.
17. Zasloff, M.: Antimicrobial peptides in health and disease. New Engl. J. Med., 2002, 147, 1199-1200. (Editorial)
18. Buck, C. B., Day, P. M., Thompson, C. D. és mtsai: Human alpha-defensins block papillomavirus infection. Proc. Natl. Acad. Sci., 2006, 103, 1516-1521.
19. Smith, J. G., Nemerow, G. R.: Mechanism of adenovirus neutralization by human alpha-defensins. Cell Host Microbe, 2008, 3, 11-19.
20. Buck, C. B.: Defensins' offensive play: exploiting a viral achilles' heel. Cell Host Microbe, 2008, 3, 3-4.
21. Kübler, I., Stange, E. F., Fellermann, K. és mtsa: Defensine: körpereigene Antibiotika als zentraler Bestandteil des angeborenen Immunsystems. Dtsch. Med. Wochenschr., 2006, 31, 1960-1964. (Review)
22. Dhople, V., Krukmeyer, A., Ramamoorthy, A.: The human beta-defensin. 3, an antibacterial peptide with multiple biological functions. Biochem. Biophys. Acta, 2006, 1758, 1499-1512.
23. Pazgier, M., Hoover, D. M., Yang, D. és mtsa: Human β-defensins. Cell. Mol. Life Sci., 2006, 63, 1294-1313. (Review)
24. Huttner, K. M.: Antimicrobial peptides - The defence never rests. In: Neuroimmune biology. Szerk.: Berczi, I., Szentiványi, A. Vol. 5: Natural Immunity. Szerk.: Bertók, L., Chow, D. A. Elsevier, Amszterdam, 2005, 39-48.
25. Oren, A., Ganz, T., Liu, L. és mtsa: In human epidermis, β defensin 2 is packaged in lamellar bodies. Exp. Molec. Pathol., 2003, 74, 180-182.
26. Schneider, J. J., Unholzer, A., Schaller, M. és mtsai: Human defensins. J. Mol. Med., 2005, 83, 587-595.
27. Klüver, E., Schulz- Maronde, S., Scheid, S. és mtsa: Structure activity relation of human beta-defensin 3: infl uence of disulfi de bonds and cysteine substitution on antimicrobial activity and citotoxicity. Biochemistry, 2005, 44, 9804-9816.
28. Kai-Larsen, Y., Agerberth, B.: The role of the multifunctional peptide LL-37 in host defense. Front Biosci., 2008, 13, 3760-3767.
29. Murakami, M., Dorschner, R. A., Stern, L. J. és mtsai: Expression and secretion of cathelicidin antimicrobial peptides in murine mammary glands and human milk. Pediatr. Res., 2005, 57, 10-15.
30. McDermott, A. M.: Defensins and other antimicrobial peptides at the ocular surface. Ocul. Surf., 2004, 2, 229-247.
31. Dürr, U. H. N., Sudheendra, U. S, Ramamoorthy, A.: LL-37, the only human member of the cathelicidin family of antimicrobial peptides. BBA. Biomembranes, 2006, 1758, 408-1425.
32. Zanetti, M.: Cathelicidins, multifunctional peptides of the innate immunity. J. Leukocyt. Biol., 2004, 75, 39-48.
33. Motzkus, D., Schulz-Maronde, S., Heiland, A. és mtsai: The novel β-defensin DEFB123 prevents lipopolysaccharide-mediated effect in vitro and in vivo. Faseb J., 2006, 20, E997-E1004.
34. Kavanagh, K., Dowd, S.: Histatins: antimicrobial peptides with therapeutic potential. J. Phar. Pharmacol., 2004, 56, 285-289.
35. Bowdish, D. M. E., Davidson, D. J., Scott, M. G. és mtsa: Im munomodulatory activities of small host defense peptides. Antimicrob. Agents Chemother., 2005, 49, 1727-1732.
36. Bowdish, D. M. E., Davidson, D. J., Hancock, R. E. W.: A reevaluation of the role of host defence peptide in mammalian immunity. Curr. Protein Pept. Sci., 2005, 6, 35-51.
37. Sands, B. E.: Infl ammatory bowel disease: past, present, and future. J. Gastroenterol., 2007, 42, 16-25. (Review)
38. Wehkamp, J., Schmid, M., Stange, E. F.: Defensins and other antimicrobial peptides in infl ammatory bowel disease. Curr. Opin. Gastroenterol., 2007, 23, 370-378.
39. Hiemstra, P. S.: Defensins and cathelicidins in infl ammatory lung disease: beyond antimicrobial activity. Biochem. Soc. Transactions, 2006, 34 (part 2), 276-278.
40. Aceti, A., Mangoni, M. L., Pasquazzi, C. és mtsai: Alpha-defensin increase in peripheral blood mononuclear cells from patients with hepatitis C virus chronic infection. J. Viral. Hepat., 2006, 13, 821-827.
41. Agerberth, B., Guömundsson, G. H.: Host antimicrobial defense peptides in human disease. CTMI, 2006, 306, 67-90. (Review) Springer Verlag, Berlin-Heidelberg, 2006.
42. Wehkamp, J., Fellermann, K., Herrlinger, K. R. és mtsai: Mechanisms of disease: defensins in gastrointestinal diseases. Nat. Clin. Prac. Gastroenterol. Hepatol., 2005, 2, 406-415.
43. Lakatos, P. L., Altorjay, I., Mándi Y. és mtsai: Interaction between seroreactivity to microbial antigens and genetics in Crohn's disease: is there a role for defensins? Tissue Antigens, 2008, 71, 552-559.
44. Nervekar, N., Lakha, F., Critchley, Ho. és mtsai: Changes in vaginal morphology, steroid receptor and natural antimicrobial content following treatment with low dose mifepristone. Contraception, 2007, 75, 271-280.
45. Simmanco, M., Boman, A., Mangoni, M. L. és mtsai: Effect of glucocorticoids on the synthesis of antimicrobial peptides in amphibian skin. FEBS Lett., 1997, 416, 273-275.
46. Biragyn, A.: Defensins - non-antibiotic use for vaccine development. Curr. Protein Pept. Sci., 2005, 6, 53-60. (Review)
47. Niyonsaba, Fr., Ogawa, H.: Protective roles of the skin against infection: Implication of naturally occurring human antimicrobial agents β-defensins, cathelicidin LL-37 and lyspzyme. J. Dermatol. Sci., 2005, 40, 157-168. (Review)